Freeze and drug combo takes aim at early lung cancer
Disease control
Not yet recruiting
This study tests a new combination treatment for people with early-stage non-small cell lung cancer who cannot or choose not to have surgery or radiation. The treatment uses a drug called serplulimab (given through a vein every 3 weeks for up to 6 cycles) along with cryoablation,…
Phase: PHASE2 • Sponsor: Xi Junjie • Aim: Disease control
Last updated May 15, 2026 11:56 UTC